Senior Vice President of MIDD Enterprise Transformation

About Certara

Certara accelerates the potential of bringing medicines to market and to patients using biosimulation software, technology, and services to transform traditional drug discovery and development. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.

Our goal is to enable the life sciences industry's use of data, modeling, and analytics to make better decisions across the various phases of discovery and drug development. Our software and scientists incorporate modern advances in scientific understanding, drug development experience, data analysis, and AI resulting in significant opportunities to decrease the cost and increase the probability of success for new drug approval and commercialization.

The (S)VP of MIDD Enterprise Transformation will serve as a collaboration point across Certara delivery and sales functions to:

1. Develop a collective view on the integrated MIDD value proposition
2. Quantify the benefit to customer segments
3. Identify and prioritize 'next level' target customers by segment (i.e., Program Leads, Development Heads etc.)
4. Enable the generation of targeted collateral and marketing campaigns
5. Develop a workshop approach to introduce integrated MIDD to customers
6. Win new enterprise transformation advisory projects
7. Increase adoption of Certara software and services
8. Create a path to material growth beginning in 2026, scaling over the next 3 years

• Portfolio & Gap Analysis: Support 'Products and Offerings Portfolio' task force reviewing Certara's software products and consulting offerings, identify under-leveraged, interconnected or adjacent capabilities and opportunities to bundle, modularize or create combinational solutions
• Client centricity: Support Sales and Marketing to solicit early market and client feedback, prioritize solutions with highest immediate need, ROI, feasibility, and alignment with Certara's scientific strengths and commercial goals
• Commercialization & Business Modelling: For top new solutions, build full business cases, including: pricing; market sizing; competitive landscape; client value proposition; path to regulatory qualification if relevant, risk assessment
• Cross-unit Integration & Process Enablers: Support 'Ways of Working' task force to establish governance, processes, incentives, and organization to enable cross-unit collaboration. For example, ensure that Simcyp modellers, QSP teams, regulatory software, and consulting services can co-develop joint offerings without double counting, friction, or competing incentives.
• Client & Stakeholder Engagement: Work closely with key clients and Commercial to validate ideas and, align internal stakeholders (Division heads, product managers, consulting leads) behind the strategy
• Operational Scaling & Delivery: Define and oversee the operations, infrastructure, product management, marketing, and support required to deliver the new offerings. Ensure quality, regulatory compliance, scientific rigor, user experience, and cost discipline.
• Metrics & Feedback Loops: Institute metrics and feedback systems to monitor progress (adoption, client satisfaction, regulatory acceptance, profitability), adjust course, kill underperforming ideas quickly, double down on high promise offerings.

Key Performance Indicators (KPIs)

To be successful in this role, the executive is expected to deliver against measurable milestones, for example:

KPI

Target / Timeline

New Offering Launches

At least two cross-unit integrated solutions fully launched by Q4 2026 , each generating at least XXX% of incremental bookings in pilot clients.

Cross-unit Revenue Growth

Increase revenue contributed by cross-unit / bundled offerings by xxx % by end of 2027 , and yyy % by end of 2028 , relative to a 2025 baseline.

Client Retention & Satisfaction

Improve client retention (for clients with multi-phase or multi-offering portfolios) by xx% and increase client satisfaction / Net Promoter Score for bundled offerings by at least yy% over current individual offering scores by end of 2027.

Operational Efficiency & Margin

New offerings should achieve target margin (software + consulting blend) that either matches or exceeds existing margins for standalone consulting or software; also reduce redundant costs or overlap between units (e.g. duplicated staffing, overlap in software licensing / infrastructure) by measurable percent (e.g. 5-10%) by end of 2027.

• Proven New Product / Consulting Offering Commercialization - experience launching services or products in the life sciences or similar technical consulting domain; including managing full lifecycle from ideation to deployment.
• Market Intelligence & Client Solutioning Expertise - ability to pick up on market trends (AI/ML in drug discovery; regulatory software automation), competitive positioning, and translate insights into offerings that directly solve client pain points and deliver measurable value.
• Digital / Platform Mindset - comfortable with software product, platform economics; experience designing or deploying digital collaboration workspaces or platforms; understanding integration, and scaling digital tools.
• Cross-Functional Leadership & Change Management - ability to influence across scientific, consulting, product, regulatory & software teams; strong operational discipline; track record of aligning and motivating stakeholders; adept at navigating matrix organizations.
• Educational Background - advanced degree in life sciences, or engineering + business credentials (MBA or similar); mix of technical credibility and commercial acumen.
• Communication & Influencing Skills - able to communicate scientific complexity and business value to senior executives; persuasive with external regulatory bodies or clients; strong ability to translate technical advantages into client ROI.

Certara bases all employment-related decision on merit, taking into consideration qualifications, skills, achievement, and performance. We treat all applicants and employees without regard to personal characteristics such as race, color, ethnicity, religion, sex, sexual orientation, age, nationality, marital status, pregnancy, physical or mental condition, genetic information, military service, or other characteristic protected by law.